illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. energy & mining
  6. ›
  7. Guangdong Hec Technology Holding
Company logo

Guangdong Hec Technology Holding | Sustainability Performance

https://www.hec-al.com/

Manufactures and markets electronic components, aluminum foils, chemical intermediates, and energy materials. Its portfolio includes electrode and battery foils, new chemical and refrigerant formulations, lithium‑based energy compounds, and magnetic materials, serving diverse industries from electronics and automotive to environmental and clean‑energy sectors.

1993

China

5,001 - 10,000 employees

Mining & Metals

$1B - 10B in revenue

$25M - 100M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#9338
Overall
#392
in China
#145
in Mining & Metals

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

357 out of 483

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Henan Shenhuo Coal Industary & Electricity Power

China, Energy & Mining, Mining & Metals


Company logo
Sichuan New Energy Power

China, Energy & Mining, Utilities


Company logo
Sinomine Resource

China, Energy & Mining, Mining & Metals

Market cap

101.9B $, 2026▼72.4% YoY

Revenue

12.2B $, 2024▼11% YoY

R&D intensity

3.84% 2024

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Guangdong HEC Technology Holding, Chinese pharmaceutical/chemicals, has faced sustained Chinese NMPA enforcement scrutiny over alleged inadequate disclosure of pharmaceutical product quality at multiple Chinese production facilities, plus the contested 2024 sustained share price volatility amid Chinese pharma market normalization affecting Hong Kong-listed institutional shareholders.
Powered by illuminem

Market cap

101.9B $, 2026▼72.4% YoY

Revenue

12.2B $, FY2024▼11% YoY

EBITDA

585.0M $, FY2024▼9.1% YoY

Operating margin

4% Industry: -40▼147.9% YoY

P/E ratio

86.9 Industry: 16▼183.4% YoY

Revenue & EBITDA

$12.2BFY2024 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-576.3M 2024▲106.1% YoY

Capex

1.1B 2024▲39.6% YoY

Debt/equity ratio

1.3 Industry: 0▼NaN% YoY

R&D intensity

3.8%FY2024

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

2.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

11.7

▼ 9.4%

2022

10.9

▼ 12.6%

2023

12.2

▼ 7.1%

2024

22.3

2027

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

20%
Independent Directors

3 out of 15 incl. management

Powered by illuminem

Overall score

65

Environment

87

Social

75

Governance

31

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email